Prospera Financial Services Inc Abbott Laboratories Transaction History

Prospera Financial Services Inc

$3.82 Billion
Q3 2024

A detailed history of Prospera Financial Services Inc transactions in Abbott Laboratories stock. As of the latest transaction made, Prospera Financial Services Inc holds 114,880 shares of ABT stock, worth $13.2 Million. This represents 0.34% of its overall portfolio holdings.

Number of Shares

114,880

Previous 107,072 7.29%

Holding current value

$13.2 Million

Previous $11.1 Million 17.73%

% of portfolio

0.34%

Previous 0.32%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	BUY	$100.07 - $118.13 $781,346 - $922,359	7,808 Added 7.29%	114,880 $13.1 Million
Q2 2024 Aug 13, 2024	BUY	$100.73 - $112.44 $1.39 Million - $1.55 Million	13,758 Added 14.74%	107,072 $11.1 Million
Q1 2024 Aug 13, 2024	SELL	$109.52 - $120.96 $647,153 - $714,752	-5,909 Reduced 5.52%	101,163 $11.5 Million
Q4 2023 Feb 14, 2024	SELL	$90.19 - $110.4 $11,724 - $14,352	-130 Reduced 0.14%	93,314 $10.3 Million
Q3 2023 Nov 13, 2023	BUY	$95.53 - $114.62 $484,337 - $581,123	5,070 Added 5.74%	93,444 $9.05 Million
Q2 2023 Aug 08, 2023	BUY	$100.78 - $112.29 $509,946 - $568,187	5,060 Added 6.07%	88,374 $9.63 Million
Q1 2023 May 12, 2023	BUY	$96.86 - $114.01 $3.1 Million - $3.65 Million	31,975 Added 62.28%	83,314 $8.44 Million
Q4 2022 Feb 08, 2023	SELL	$95.06 - $111.52 $2.12 Million - $2.49 Million	-22,302 Reduced 30.28%	51,339 $5.64 Million
Q3 2022 Oct 27, 2022	BUY	$96.76 - $112.03 $143,204 - $165,804	1,480 Added 2.05%	73,641 $7.13 Million
Q2 2022 Aug 08, 2022	BUY	$102.07 - $123.37 $291,001 - $351,727	2,851 Added 4.11%	72,161 $7.84 Million
Q1 2022 May 04, 2022	SELL	$114.02 - $139.04 $1.66 Million - $2.02 Million	-14,546 Reduced 17.35%	69,310 $8.21 Million
Q4 2021 Feb 10, 2022	BUY	$115.53 - $141.46 $2.83 Million - $3.47 Million	24,504 Added 41.29%	83,856 $11.8 Million
Q3 2021 Nov 12, 2021	BUY	$116.66 - $129.06 $270,184 - $298,902	2,316 Added 4.06%	59,352 $7.01 Million
Q2 2021 Aug 12, 2021	BUY	$105.79 - $124.53 $203,328 - $239,346	1,922 Added 3.49%	57,036 $6.61 Million
Q1 2021 May 06, 2021	BUY	$108.84 - $128.23 $499,249 - $588,191	4,587 Added 9.08%	55,114 $6.61 Million
Q4 2020 Feb 12, 2021	BUY	$105.0 - $114.42 $5.31 Million - $5.78 Million	50,527 New	50,527 $5.53 Million
Q3 2020 Nov 04, 2020	SELL	$91.64 - $111.29 $4.68 Million - $5.68 Million	-51,047 Closed	0 $0
Q2 2020 Aug 07, 2020	BUY	$76.57 - $98.0 $240,046 - $307,230	3,135 Added 6.54%	51,047 $4.67 Million
Q1 2020 May 15, 2020	BUY	$62.82 - $91.86 $370,638 - $541,974	5,900 Added 14.04%	47,912 $3.78 Million
Q4 2019 Feb 12, 2020	BUY	$78.51 - $87.4 $1.71 Million - $1.9 Million	21,794 Added 107.8%	42,012 $3.65 Million
Q3 2019 Oct 22, 2019	BUY	$81.84 - $88.74 $294,951 - $319,818	3,604 Added 21.69%	20,218 $1.69 Million
Q2 2019 Aug 14, 2019	SELL	$72.88 - $85.0 $145,978 - $170,255	-2,003 Reduced 11.43%	15,522 $1.11 Million
Q2 2019 Aug 14, 2019	BUY	$72.88 - $85.0 $79,584 - $92,820	1,092 Added 7.04%	16,614 $1.41 Million
Q1 2019 May 02, 2019	BUY	$66.22 - $80.06 $132,638 - $160,360	2,003 Added 12.9%	17,525 $1.38 Million
Q4 2018 Feb 13, 2019	BUY	$65.56 - $74.27 $103,125 - $116,826	1,573 Added 11.28%	15,522 $1.11 Million
Q3 2018 Oct 25, 2018	BUY	$60.81 - $73.36 $13,439 - $16,212	221 Added 1.61%	13,949 $869,000
Q2 2018 Jul 18, 2018	SELL	$57.57 - $63.54 $9,268 - $10,229	-161 Reduced 1.16%	13,728 $838,000
Q1 2018 Apr 12, 2018	SELL	$56.27 - $63.62 $98,641 - $111,525	-1,753 Reduced 11.21%	13,889 $832,000
Q4 2017 Jan 24, 2018	SELL	$53.68 - $57.47 $42,782 - $45,803	-797 Reduced 4.85%	15,642 $900,000
Q3 2017 Oct 11, 2017	BUY	$48.06 - $53.64 $790,058 - $881,787	16,439	16,439 $886,000

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $201B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Prospera Financial Services Inc, based on Form 13F filings with the SEC.

News

Stay updated on Prospera Financial Services Inc with notifications on news.

Account

Prospera Financial Services Inc Abbott Laboratories Transaction History